Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 279

1.

Second generation of diazachrysenes: Protection of Ebola virus infected mice and mechanism of action.

Selaković Ž, Tran JP, Kota KP, Lazić M, Retterer C, Besh R, Panchal RG, Soloveva V, Sean VA, Jay WB, Pavić A, Verbić T, Vasiljević B, Kuehl K, Duplantier AJ, Bavari S, Mudhasani R, Šolaja BA.

Eur J Med Chem. 2018 Oct 31;162:32-50. doi: 10.1016/j.ejmech.2018.10.061. [Epub ahead of print]

PMID:
30408747
2.

Ebola Virus Causes Intestinal Tract Architectural Disruption and Bacterial Invasion in Non-Human Primates.

Reisler RB, Zeng X, Schellhase CW, Bearss JJ, Warren TK, Trefry JC, Christopher GW, Kortepeter MG, Bavari S, Cardile AP.

Viruses. 2018 Sep 20;10(10). pii: E513. doi: 10.3390/v10100513.

3.

Persistent Marburg Virus Infection in the Testes of Nonhuman Primate Survivors.

Coffin KM, Liu J, Warren TK, Blancett CD, Kuehl KA, Nichols DK, Bearss JJ, Schellhase CW, Retterer CJ, Weidner JM, Radoshitzky SR, Brannan JM, Cardile AP, Dye JM, Palacios G, Sun MG, Kuhn JH, Bavari S, Zeng X.

Cell Host Microbe. 2018 Sep 12;24(3):405-416.e3. doi: 10.1016/j.chom.2018.08.003. Epub 2018 Aug 30.

PMID:
30173956
4.

DDX3 suppresses type I interferons and favors viral replication during Arenavirus infection.

Loureiro ME, Zorzetto-Fernandes AL, Radoshitzky S, Chi X, Dallari S, Marooki N, Lèger P, Foscaldi S, Harjono V, Sharma S, Zid BM, López N, de la Torre JC, Bavari S, Zúñiga E.

PLoS Pathog. 2018 Jul 12;14(7):e1007125. doi: 10.1371/journal.ppat.1007125. eCollection 2018 Jul.

5.

Repurposing potential of 1st generation H1-specific antihistamines as anti-filovirus therapeutics.

Schafer A, Cheng H, Xiong R, Soloveva V, Retterer C, Mo F, Bavari S, Thatcher G, Rong L.

Antiviral Res. 2018 Sep;157:47-56. doi: 10.1016/j.antiviral.2018.07.003. Epub 2018 Jul 4.

PMID:
29981374
6.

Role of Antibodies in Protection Against Ebola Virus in Nonhuman Primates Immunized With Three Vaccine Platforms.

Warfield KL, Howell KA, Vu H, Geisbert J, Wong G, Shulenin S, Sproule S, Holtsberg FW, Leung DW, Amarasinghe GK, Swenson DL, Bavari S, Kobinger GP, Geisbert TW, Aman MJ.

J Infect Dis. 2018 Jun 25. doi: 10.1093/infdis/jiy316. [Epub ahead of print]

PMID:
29939318
7.

Countering Zika Virus: The USAMRIID Response.

Lowen RG, Bocan TM, Kane CD, Cazares LH, Kota KP, Ladner JT, Nasar F, Pitt L, Smith DR, Soloveva V, Sun MG, Zeng X, Bavari S.

Adv Exp Med Biol. 2018;1062:303-318. doi: 10.1007/978-981-10-8727-1_21.

PMID:
29845541
8.

Taxonomy of the order Mononegavirales: update 2018.

Amarasinghe GK, Aréchiga Ceballos NG, Banyard AC, Basler CF, Bavari S, Bennett AJ, Blasdell KR, Briese T, Bukreyev A, Caì Y, Calisher CH, Campos Lawson C, Chandran K, Chapman CA, Chiu CY, Choi KS, Collins PL, Dietzgen RG, Dolja VV, Dolnik O, Domier LL, Dürrwald R, Dye JM, Easton AJ, Ebihara H, Echevarría JE, Fooks AR, Formenty PBH, Fouchier RAM, Freuling CM, Ghedin E, Goldberg TL, Hewson R, Horie M, Hyndman TH, Jiāng D, Kityo R, Kobinger GP, Kondō H, Koonin EV, Krupovic M, Kurath G, Lamb RA, Lee B, Leroy EM, Maes P, Maisner A, Marston DA, Mor SK, Müller T, Mühlberger E, Ramírez VMN, Netesov SV, Ng TFF, Nowotny N, Palacios G, Patterson JL, Pawęska JT, Payne SL, Prieto K, Rima BK, Rota P, Rubbenstroth D, Schwemmle M, Siddell S, Smither SJ, Song Q, Song T, Stenglein MD, Stone DM, Takada A, Tesh RB, Thomazelli LM, Tomonaga K, Tordo N, Towner JS, Vasilakis N, Vázquez-Morón S, Verdugo C, Volchkov VE, Wahl V, Walker PJ, Wang D, Wang LF, Wellehan JFX, Wiley MR, Whitfield AE, Wolf YI, Yè G, Zhāng YZ, Kuhn JH.

Arch Virol. 2018 Aug;163(8):2283-2294. doi: 10.1007/s00705-018-3814-x. Epub 2018 Apr 11.

PMID:
29637429
9.

Ebola Virus Persistence in Ocular Tissues and Fluids (EVICT) Study: Reverse Transcription-Polymerase Chain Reaction and Cataract Surgery Outcomes of Ebola Survivors in Sierra Leone.

Shantha JG, Mattia JG, Goba A, Barnes KG, Ebrahim FK, Kraft CS, Hayek BR, Hartnett JN, Shaffer JG, Schieffelin JS, Sandi JD, Momoh M, Jalloh S, Grant DS, Dierberg K, Chang J, Mishra S, Chan AK, Fowler R, O'Dempsey T, Kaluma E, Hendricks T, Reiners R, Reiners M, Gess LA, ONeill K, Kamara S, Wurie A, Mansaray M, Acharya NR, Liu WJ, Bavari S, Palacios G, Teshome M, Crozier I, Farmer PE, Uyeki TM, Bausch DG, Garry RF, Vandy MJ, Yeh S.

EBioMedicine. 2018 Apr;30:217-224. doi: 10.1016/j.ebiom.2018.03.020. Epub 2018 Mar 23.

10.

Ribavirin Had Demonstrable Effects on the Crimean-Congo Hemorrhagic Fever Virus (CCHFV) Population and Load in a Patient With CCHF Infection.

Espy N, Pérez-Sautu U, Ramírez de Arellano E, Negredo A, Wiley MR, Bavari S, Díaz Menendez M, Sánchez-Seco MP, Palacios G.

J Infect Dis. 2018 May 25;217(12):1952-1956. doi: 10.1093/infdis/jiy163.

PMID:
29584885
11.

Zika Virus Infection in Syrian Golden Hamsters and Strain 13 Guinea Pigs.

Miller LJ, Nasar F, Schellhase CW, Norris SL, Kimmel AE, Valdez SM, Wollen-Roberts SE, Shamblin JD, Sprague TR, Lugo-Roman LA, Jarman RG, Yoon IK, Alera MT, Bavari S, Pitt MLM, Haddow AD.

Am J Trop Med Hyg. 2018 Mar;98(3):864-867. doi: 10.4269/ajtmh.17-0686. Epub 2018 Feb 1.

PMID:
29405107
12.

New Steroidal 4-Aminoquinolines Antagonize Botulinum Neurotoxin Serotype A in Mouse Embryonic Stem Cell Derived Motor Neurons in Postintoxication Model.

Konstantinović J, Kiris E, Kota KP, Kugelman-Tonos J, Videnović M, Cazares LH, Terzić Jovanović N, Verbić TŽ, Andjelković B, Duplantier AJ, Bavari S, Šolaja BA.

J Med Chem. 2018 Feb 22;61(4):1595-1608. doi: 10.1021/acs.jmedchem.7b01710. Epub 2018 Feb 6.

PMID:
29385334
13.

High degree of correlation between Ebola virus BSL-4 neutralization assays and pseudotyped VSV BSL-2 fluorescence reduction neutralization test.

Konduru K, Shurtleff AC, Bavari S, Kaplan G.

J Virol Methods. 2018 Apr;254:1-7. doi: 10.1016/j.jviromet.2018.01.003. Epub 2018 Jan 31.

PMID:
29355585
14.

Histology, immunohistochemistry, and in situ hybridization reveal overlooked Ebola virus target tissues in the Ebola virus disease guinea pig model.

Cooper TK, Huzella L, Johnson JC, Rojas O, Yellayi S, Sun MG, Bavari S, Bonilla A, Hart R, Jahrling PB, Kuhn JH, Zeng X.

Sci Rep. 2018 Jan 19;8(1):1250. doi: 10.1038/s41598-018-19638-x.

15.

Efficacy of favipiravir (T-705) in nonhuman primates infected with Ebola virus or Marburg virus.

Bixler SL, Bocan TM, Wells J, Wetzel KS, Van Tongeren SA, Dong L, Garza NL, Donnelly G, Cazares LH, Nuss J, Soloveva V, Koistinen KA, Welch L, Epstein C, Liang LF, Giesing D, Lenk R, Bavari S, Warren TK.

Antiviral Res. 2018 Mar;151:97-104. doi: 10.1016/j.antiviral.2017.12.021. Epub 2017 Dec 28.

16.

Intracellular conversion and in vivo dose response of favipiravir (T-705) in rodents infected with Ebola virus.

Bixler SL, Bocan TM, Wells J, Wetzel KS, Van Tongeren SA, Garza NL, Donnelly G, Cazares LH, Soloveva V, Welch L, Epstein C, Liang LF, Giesing D, Lenk R, Bavari S, Warren TK.

Antiviral Res. 2018 Mar;151:50-54. doi: 10.1016/j.antiviral.2017.12.020. Epub 2017 Dec 28.

17.

African and Asian Zika Virus Isolates Display Phenotypic Differences Both In Vitro and In Vivo.

Smith DR, Sprague TR, Hollidge BS, Valdez SM, Padilla SL, Bellanca SA, Golden JW, Coyne SR, Kulesh DA, Miller LJ, Haddow AD, Koehler JW, Gromowski GD, Jarman RG, Alera MTP, Yoon IK, Buathong R, Lowen RG, Kane CD, Minogue TD, Bavari S, Tesh RB, Weaver SC, Linthicum KJ, Pitt ML, Nasar F.

Am J Trop Med Hyg. 2018 Feb;98(2):432-444. doi: 10.4269/ajtmh.17-0685. Epub 2017 Dec 21.

PMID:
29280428
18.

Clinical Laboratory Values in Human Ebola Virus Disease Support the Relevance of the Intramuscular Ebola-Kikwit Rhesus Model.

Reisler RB, Kraft CS, Bavari S, Cardile AP.

Clin Infect Dis. 2018 Apr 17;66(9):1479-1480. doi: 10.1093/cid/cix1025. No abstract available.

PMID:
29272400
19.

Enhancing the antiviral potency of ER α-glucosidase inhibitor IHVR-19029 against hemorrhagic fever viruses in vitro and in vivo.

Ma J, Zhang X, Soloveva V, Warren T, Guo F, Wu S, Lu H, Guo J, Su Q, Shen H, Solon E, Comunale MA, Mehta A, Guo JT, Bavari S, Du Y, Block TM, Chang J.

Antiviral Res. 2018 Feb;150:112-122. doi: 10.1016/j.antiviral.2017.12.008. Epub 2017 Dec 15.

PMID:
29253498
20.

Treatment-focused Ebola trials, supportive care and future of filovirus care.

Keshtkar-Jahromi M, Martins KAO, Cardile AP, Reisler RB, Christopher GW, Bavari S.

Expert Rev Anti Infect Ther. 2018 Jan;16(1):67-76. doi: 10.1080/14787210.2018.1413937. Epub 2017 Dec 20. Review.

PMID:
29210303
21.

Retrovirus-Based Surrogate Systems for BSL-2 High-Throughput Screening of Antivirals Targeting BSL-3/4 Hemorrhagic Fever-Causing Viruses.

Radoshitzky SR, Soloveva V, Gharaibeh D, Kuhn JH, Bavari S.

Methods Mol Biol. 2018;1604:393-403. doi: 10.1007/978-1-4939-6981-4_29.

PMID:
28986850
22.

Discovering Drugs for the Treatment of Ebola Virus.

Bixler SL, Duplantier AJ, Bavari S.

Curr Treat Options Infect Dis. 2017;9(3):299-317. doi: 10.1007/s40506-017-0130-z. Epub 2017 Aug 4. Review.

23.

Quantitative Analysis of Repertoire-Scale Immunoglobulin Properties in Vaccine-Induced B-Cell Responses.

Khavrutskii IV, Chaudhury S, Stronsky SM, Lee DW, Benko JG, Wallqvist A, Bavari S, Cooper CL.

Front Immunol. 2017 Aug 14;8:910. doi: 10.3389/fimmu.2017.00910. eCollection 2017.

24.

Sorafenib Impedes Rift Valley Fever Virus Egress by Inhibiting Valosin-Containing Protein Function in the Cellular Secretory Pathway.

Brahms A, Mudhasani R, Pinkham C, Kota K, Nasar F, Zamani R, Bavari S, Kehn-Hall K.

J Virol. 2017 Oct 13;91(21). pii: e00968-17. doi: 10.1128/JVI.00968-17. Print 2017 Nov 1.

25.

Clinical Laboratory Values as Early Indicators of Ebola Virus Infection in Nonhuman Primates.

Reisler RB, Yu C, Donofrio MJ, Warren TK, Wells JB, Stuthman KS, Garza NL, Vantongeren SA, Donnelly GC, Kane CD, Kortepeter MG, Bavari S, Cardile AP.

Emerg Infect Dis. 2017 Aug;23(8):1316-1324. doi: 10.3201/eid2308.170029.

26.

Identification and pathological characterization of persistent asymptomatic Ebola virus infection in rhesus monkeys.

Zeng X, Blancett CD, Koistinen KA, Schellhase CW, Bearss JJ, Radoshitzky SR, Honnold SP, Chance TB, Warren TK, Froude JW, Cashman KA, Dye JM, Bavari S, Palacios G, Kuhn JH, Sun MG.

Nat Microbiol. 2017 Jul 17;2:17113. doi: 10.1038/nmicrobiol.2017.113.

PMID:
28715405
27.

Identification of a coumarin-based antihistamine-like small molecule as an anti-filoviral entry inhibitor.

Cheng H, Schafer A, Soloveva V, Gharaibeh D, Kenny T, Retterer C, Zamani R, Bavari S, Peet NP, Rong L.

Antiviral Res. 2017 Sep;145:24-32. doi: 10.1016/j.antiviral.2017.06.015. Epub 2017 Jun 20.

28.

T-cell-dependent mechanisms promote Ebola VLP-induced antibody responses, but are dispensable for vaccine-mediated protection.

Cooper CL, Martins KA, Stronsky SM, Langan DP, Steffens J, Van Tongeren S, Bavari S.

Emerg Microbes Infect. 2017 Jun 7;6(6):e46. doi: 10.1038/emi.2017.31.

29.

Deubiquitinating enzyme VCIP135 dictates the duration of botulinum neurotoxin type A intoxication.

Tsai YC, Kotiya A, Kiris E, Yang M, Bavari S, Tessarollo L, Oyler GA, Weissman AM.

Proc Natl Acad Sci U S A. 2017 Jun 27;114(26):E5158-E5166. doi: 10.1073/pnas.1621076114. Epub 2017 Jun 5.

30.

High Infection Rates for Adult Macaques after Intravaginal or Intrarectal Inoculation with Zika Virus.

Haddow AD, Nalca A, Rossi FD, Miller LJ, Wiley MR, Perez-Sautu U, Washington SC, Norris SL, Wollen-Roberts SE, Shamblin JD, Kimmel AE, Bloomfield HA, Valdez SM, Sprague TR, Principe LM, Bellanca SA, Cinkovich SS, Lugo-Roman L, Cazares LH, Pratt WD, Palacios GF, Bavari S, Pitt ML, Nasar F.

Emerg Infect Dis. 2017 Aug;23(8):1274-1281. doi: 10.3201/eid2308.170036. Epub 2017 Aug 15.

31.

Implementation of Objective PASC-Derived Taxon Demarcation Criteria for Official Classification of Filoviruses.

Bào Y, Amarasinghe GK, Basler CF, Bavari S, Bukreyev A, Chandran K, Dolnik O, Dye JM, Ebihara H, Formenty P, Hewson R, Kobinger GP, Leroy EM, Mühlberger E, Netesov SV, Patterson JL, Paweska JT, Smither SJ, Takada A, Towner JS, Volchkov VE, Wahl-Jensen V, Kuhn JH.

Viruses. 2017 May 11;9(5). pii: E106. doi: 10.3390/v9050106.

32.

Low potential for mechanical transmission of Ebola virus via house flies (Musca domestica).

Haddow AD, Nasar F, Schellhase CW, Moon RD, Padilla SL, Zeng X, Wollen-Roberts SE, Shamblin JD, Grimes EC, Zelko JM, Linthicum KJ, Bavari S, Pitt ML, Trefry JC.

Parasit Vectors. 2017 May 3;10(1):218. doi: 10.1186/s13071-017-2149-x.

33.

Flex-nucleoside analogues - Novel therapeutics against filoviruses.

Yates MK, Raje MR, Chatterjee P, Spiropoulou CF, Bavari S, Flint M, Soloveva V, Seley-Radtke KL.

Bioorg Med Chem Lett. 2017 Jun 15;27(12):2800-2802. doi: 10.1016/j.bmcl.2017.04.069. Epub 2017 Apr 22.

34.

Taxonomy of the order Mononegavirales: update 2017.

Amarasinghe GK, Bào Y, Basler CF, Bavari S, Beer M, Bejerman N, Blasdell KR, Bochnowski A, Briese T, Bukreyev A, Calisher CH, Chandran K, Collins PL, Dietzgen RG, Dolnik O, Dürrwald R, Dye JM, Easton AJ, Ebihara H, Fang Q, Formenty P, Fouchier RAM, Ghedin E, Harding RM, Hewson R, Higgins CM, Hong J, Horie M, James AP, Jiāng D, Kobinger GP, Kondo H, Kurath G, Lamb RA, Lee B, Leroy EM, Li M, Maisner A, Mühlberger E, Netesov SV, Nowotny N, Patterson JL, Payne SL, Paweska JT, Pearson MN, Randall RE, Revill PA, Rima BK, Rota P, Rubbenstroth D, Schwemmle M, Smither SJ, Song Q, Stone DM, Takada A, Terregino C, Tesh RB, Tomonaga K, Tordo N, Towner JS, Vasilakis N, Volchkov VE, Wahl-Jensen V, Walker PJ, Wang B, Wang D, Wang F, Wang LF, Werren JH, Whitfield AE, Yan Z, Ye G, Kuhn JH.

Arch Virol. 2017 Aug;162(8):2493-2504. doi: 10.1007/s00705-017-3311-7. Epub 2017 Apr 7.

35.

Discovery of Novel Small-Molecule Inhibitors of LIM Domain Kinase for Inhibiting HIV-1.

Yi F, Guo J, Dabbagh D, Spear M, He S, Kehn-Hall K, Fontenot J, Yin Y, Bibian M, Park CM, Zheng K, Park HJ, Soloveva V, Gharaibeh D, Retterer C, Zamani R, Pitt ML, Naughton J, Jiang Y, Shang H, Hakami RM, Ling B, Young JAT, Bavari S, Xu X, Feng Y, Wu Y.

J Virol. 2017 Jun 9;91(13). pii: e02418-16. doi: 10.1128/JVI.02418-16. Print 2017 Jul 1.

36.

Asymptomatic Ebola virus infections-myth or reality?

Kuhn JH, Bavari S.

Lancet Infect Dis. 2017 Jun;17(6):570-571. doi: 10.1016/S1473-3099(17)30110-X. Epub 2017 Feb 28. No abstract available.

37.

BRILIA: Integrated Tool for High-Throughput Annotation and Lineage Tree Assembly of B-Cell Repertoires.

Lee DW, Khavrutskii IV, Wallqvist A, Bavari S, Cooper CL, Chaudhury S.

Front Immunol. 2017 Jan 17;7:681. doi: 10.3389/fimmu.2016.00681. eCollection 2016.

38.

Therapeutic potential of the heme oxygenase-1 inducer hemin against Ebola virus infection.

Huang H, Konduru K, Solovena V, Zhou ZH, Kumari N, Takeda K, Nekhai S, Bavari S, Kaplan GG, Yamada KM, Dhawan S.

Curr Trends Immunol. 2016;17:117-123.

39.

Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo[2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses.

Siegel D, Hui HC, Doerffler E, Clarke MO, Chun K, Zhang L, Neville S, Carra E, Lew W, Ross B, Wang Q, Wolfe L, Jordan R, Soloveva V, Knox J, Perry J, Perron M, Stray KM, Barauskas O, Feng JY, Xu Y, Lee G, Rheingold AL, Ray AS, Bannister R, Strickley R, Swaminathan S, Lee WA, Bavari S, Cihlar T, Lo MK, Warren TK, Mackman RL.

J Med Chem. 2017 Mar 9;60(5):1648-1661. doi: 10.1021/acs.jmedchem.6b01594. Epub 2017 Feb 14.

PMID:
28124907
40.

Neuropathogenesis of Zika Virus in a Highly Susceptible Immunocompetent Mouse Model after Antibody Blockade of Type I Interferon.

Smith DR, Hollidge B, Daye S, Zeng X, Blancett C, Kuszpit K, Bocan T, Koehler JW, Coyne S, Minogue T, Kenny T, Chi X, Yim S, Miller L, Schmaljohn C, Bavari S, Golden JW.

PLoS Negl Trop Dis. 2017 Jan 9;11(1):e0005296. doi: 10.1371/journal.pntd.0005296. eCollection 2017 Jan.

41.

Will There Be a Cure for Ebola?

Cardile AP, Warren TK, Martins KA, Reisler RB, Bavari S.

Annu Rev Pharmacol Toxicol. 2017 Jan 6;57:329-348. doi: 10.1146/annurev-pharmtox-010716-105055. Epub 2016 Dec 7. Review.

PMID:
27959624
42.

Possibility and Challenges of Conversion of Current Virus Species Names to Linnaean Binomials.

Postler TS, Clawson AN, Amarasinghe GK, Basler CF, Bavari S, Benko M, Blasdell KR, Briese T, Buchmeier MJ, Bukreyev A, Calisher CH, Chandran K, Charrel R, Clegg CS, Collins PL, Juan Carlos T, Derisi JL, Dietzgen RG, Dolnik O, Dürrwald R, Dye JM, Easton AJ, Emonet S, Formenty P, Fouchier RAM, Ghedin E, Gonzalez JP, Harrach B, Hewson R, Horie M, Jiang D, Kobinger G, Kondo H, Kropinski AM, Krupovic M, Kurath G, Lamb RA, Leroy EM, Lukashevich IS, Maisner A, Mushegian AR, Netesov SV, Nowotny N, Patterson JL, Payne SL, PaWeska JT, Peters CJ, Radoshitzky SR, Rima BK, Romanowski V, Rubbenstroth D, Sabanadzovic S, Sanfaçon H, Salvato MS, Schwemmle M, Smither SJ, Stenglein MD, Stone DM, Takada A, Tesh RB, Tomonaga K, Tordo N, Towner JS, Vasilakis N, Volchkov VE, Wahl-Jensen V, Walker PJ, Wang LF, Varsani A, Whitfield AE, Zerbini FM, Kuhn JH.

Syst Biol. 2017 May 1;66(3):463-473. doi: 10.1093/sysbio/syw096.

43.

Antiviral therapeutics for the treatment of Ebola virus infection.

Cardile AP, Downey LG, Wiseman PD, Warren TK, Bavari S.

Curr Opin Pharmacol. 2016 Oct;30:138-143. doi: 10.1016/j.coph.2016.08.016. Review.

PMID:
27639220
44.

Bithionol blocks pathogenicity of bacterial toxins, ricin, and Zika virus.

Leonardi W, Zilbermintz L, Cheng LW, Zozaya J, Tran SH, Elliott JH, Polukhina K, Manasherob R, Li A, Chi X, Gharaibeh D, Kenny T, Zamani R, Soloveva V, Haddow AD, Nasar F, Bavari S, Bassik MC, Cohen SN, Levitin A, Martchenko M.

Sci Rep. 2016 Sep 30;6:34475. doi: 10.1038/srep34475.

45.

Ebolavirus Glycoprotein Fc Fusion Protein Protects Guinea Pigs against Lethal Challenge.

Konduru K, Shurtleff AC, Bradfute SB, Nakamura S, Bavari S, Kaplan G.

PLoS One. 2016 Sep 13;11(9):e0162446. doi: 10.1371/journal.pone.0162446. eCollection 2016.

46.

Development of a liquid chromatography high resolution mass spectrometry method for the quantitation of viral envelope glycoprotein in Ebola virus-like particle vaccine preparations.

Cazares LH, Ward MD, Brueggemann EE, Kenny T, Demond P, Mahone CR, Martins KA, Nuss JE, Glaros T, Bavari S.

Clin Proteomics. 2016 Sep 5;13(1):18. doi: 10.1186/s12014-016-9119-8. eCollection 2016.

47.

Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single dose.

Chahal JS, Khan OF, Cooper CL, McPartlan JS, Tsosie JK, Tilley LD, Sidik SM, Lourido S, Langer R, Bavari S, Ploegh HL, Anderson DG.

Proc Natl Acad Sci U S A. 2016 Jul 19;113(29):E4133-42. doi: 10.1073/pnas.1600299113. Epub 2016 Jul 5. Erratum in: Proc Natl Acad Sci U S A. 2016 Aug 30;113(35):E5250.

48.

Biochip for the Detection of Bacillus anthracis Lethal Factor and Therapeutic Agents against Anthrax Toxins.

Silin V, Kasianowicz JJ, Michelman-Ribeiro A, Panchal RG, Bavari S, Robertson JW.

Membranes (Basel). 2016 Jun 24;6(3). pii: E36. doi: 10.3390/membranes6030036.

49.

Considerations for the development of Zika virus vaccines.

Martins KA, Dye JM, Bavari S.

Vaccine. 2016 Jul 19;34(33):3711-2. doi: 10.1016/j.vaccine.2016.06.012. Epub 2016 Jun 16. No abstract available.

PMID:
27318417
50.

Neglected filoviruses.

Burk R, Bollinger L, Johnson JC, Wada J, Radoshitzky SR, Palacios G, Bavari S, Jahrling PB, Kuhn JH.

FEMS Microbiol Rev. 2016 Jul;40(4):494-519. doi: 10.1093/femsre/fuw010. Epub 2016 Jun 5. Review.

Supplemental Content

Loading ...
Support Center